glp 1 agonist statpearls The expanding scope of GLP-1 receptor agonists: Six uses beyond diabetes glp-1_analogs [TUSOM | Pharmwiki]

Earlier this month (June 2025), Novo Nordisk reported that it will advance to Phase III trials both subcutaneous and oral amycretin in weight management based on completed clinical studies

Between August 2021 and 2023, 40.3% of Americans had a body mass index (BMI) 30

Tirzepatides Role in OSA Treatment Tirzepatide represents an additional treatment option for BetterNight patients with moderate-to-severe OSA and obesity

Sometimes the issue is caloric creep, gradual increases in portion sizes or snack frequency that accumulate without being noticed

New antidiabetic and anti-obesity drugs

Research-grade peptides sold by chemical suppliers operate under different regulatory frameworks than compounded pharmaceuticals dispensed by licensed pharmacies with prescriptions